AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Carvitab 12.5 Tablet

Prescription Icon
Prescription Required

Marketer

ADN Life Sciences

Salt Composition

Carvedilol (12.5mg)

Overview Carvitab 12.5 Tablet

CardioVas 12.5mg tablets manage hypertension, angina pectoris, and congestive heart failure. Its mechanism involves vasodilation, improving blood flow to the heart. Reduced blood pressure minimizes stroke and myocardial infarction risk. Administer CardioVas 12.5mg with meals, following your physician's prescribed dosage and regimen. Continue treatment even with symptom improvement or controlled blood pressure. Discontinue only under medical supervision, as abrupt cessation may worsen your condition. Lifestyle modifications, including regular physical activity, weight management, smoking cessation, moderate alcohol consumption, and a low-sodium diet (as directed by your doctor), are beneficial. While generally well-tolerated, potential side effects include vertigo, cephalgia, dyspnea, and fatigue. Report persistent or bothersome side effects to your doctor. Prior to commencing treatment, disclose any pre-existing cardiac or renal conditions to your physician. Consult your doctor before using this medication if you are pregnant or lactating.

Uses of Carvitab 12.5 Tablet

Managing high blood pressure | Addressing angina pectoris | Cardiac failure management

Major Benefits of Carvitab 12.5 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Carvitab 12.5 Tablets should be taken with a meal.

Common Side effects of Carvitab 12.5 Tablet:

  • Decreased blood pressure
  • Headache
  • Fatigue
  • Dizziness
  • Breathlessness

How to use Carvitab 12.5 Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Carvitab 12.5 Tablet with a meal.

How Carvitab 12.5 Tablet works:

Carvitab 12.5mg tablets combine alpha and beta-blocking properties. This dual action reduces heart rate and dilates blood vessels, thereby improving the heart's pumping efficiency.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Carvitab 12.5 Tablet and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Carvitab 12.5 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Always seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The use of Carvitab 12.5 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Taking Carvitab 12.5 Tablet might reduce awareness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these side effects develop.

KidneyKidneySAFE IF PRESCRIBED

Carvitab 12.5mg tablets may be used safely by individuals with kidney disease without requiring a dosage change. Nevertheless, disclosure of any pre-existing kidney condition to your physician is advised. Routine blood pressure checks are suggested to guide dosage modifications as needed.

LiverLiverCAUTION

Patients with liver impairment should use Carvitab 12.5 mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Carvitab 12.5 mg tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Carvitab 12.5 Tablet :

Should you forget to take your Carvitab 12.5 Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Carvitab 12.5 Tablet

LabelValue
Type of Compound Carbazole-based compound with a propanol moiety
Addictive None.
Medication Classification Heart-related
Mechanism of Action Combined alpha and beta adrenergic antagonist

FAQs on Carvitab 12.5 Tablet

Consistent use of Carvitab 12.5mg tablets, as prescribed by your physician, is crucial. Abrupt discontinuation may lead to cardiac discomfort or myocardial infarction. To safely discontinue treatment, your doctor might gradually reduce your dosage.
Fatigue and dizziness are possible side effects of Carvitab 12.5 Tablet, particularly at treatment initiation or following dose escalation. Driving or operating machinery should be avoided if these effects occur.
Weight increase is a frequently reported side effect of Carvitab 12.5 Tablet, though not universal. Patients using Carvitab 12.5 Tablet for congestive heart failure should report any significant weight gain or shortness of breath to their physician; these could indicate fluid buildup.
Kidney function decline is an uncommon but possible side effect of Carvitab 12.5 Tablet in heart failure patients. The risk of kidney failure from Carvitab 12.5 Tablet is elevated in individuals with low blood pressure (systolic below 100 mm Hg), atherosclerosis, pre-existing heart disease, or compromised kidney function. Close monitoring is essential for these patients while taking Carvitab 12.5 Tablet. Kidney function typically recovers upon discontinuation of Carvitab 12.5 Tablet.
Diabetic patients may use Carvitab 12.5 Tablets, but consistent blood glucose monitoring is crucial. Studies show minimal impact on blood sugar in well-managed diabetes with mild to moderate hypertension. However, beta-blockers, the drug class of Carvitab 12.5 Tablets, can mask hypoglycemic symptoms like tachycardia. Furthermore, Carvitab 12.5 Tablets might exacerbate hyperglycemia in diabetic patients with heart failure. Therefore, close blood glucose monitoring is advised when starting, altering, or stopping Carvitab 12.5 Tablet treatment. Report any blood sugar fluctuations to your physician during therapy.
Taking Carvitab 12.5 Tablet with food is advised. Food slows the medication's absorption, thus minimizing the risk of orthostatic hypotension—a drop in blood pressure potentially causing dizziness or fainting upon standing.
Taking Carvitab 12.5 Tablets can lead to severe adverse reactions including dizziness, respiratory distress, increased body weight, and edema in the extremities. Other potential side effects are chest discomfort, bradycardia or arrhythmia, skin eruptions, urticaria, pruritus, and dysphagia. Seek immediate medical attention if any of these occur.
Exceeding the prescribed dosage of Carvitab 12.5 Tablet can lead to bradycardia, lightheadedness, syncope, respiratory distress, emesis, and potential loss of consciousness or convulsions. Consult your physician and obtain prompt medical attention at the nearest hospital.
Use of Carvitab 12.5 Tablet is contraindicated for patients with severe heart failure requiring intensive care unit admission or treatment with circulatory support drugs (inotropes). Furthermore, this medication should be avoided in individuals with a history of asthma or respiratory difficulties, bradycardia or arrhythmias, hepatic impairment, or known hypersensitivity to Carvitab 12.5 Tablet.
Carvitab 12.5 Tablet
81
MRP 99
18% off